Invasive Species Terminology: Standardizing for Stakeholder Education

The excessive number of terms associated with invasive species, and their often incorrect usage, hinders stakeholder education about the threats of invasive species. Here we introduce seven terms (native, nonnative, introduced, established, invasive, nuisance, and range change) that are applicable across invasive taxa, understandable, typically interpreted correctly, and useful for describing most situations regarding invasive species. We also list six terms to avoid (native invasive, invasive exotic, invasive weed, alien, foreign, and nonindigenous) that create confusion via their misuse and misinterpretation. The terms we propose will increase understanding, thereby promoting behavior changes aimed at limiting the negative impacts of invasive species

Why Are Computational Neuroscience and Systems Biology So Separate?

Despite similar computational approaches, there is surprisingly little interaction between the computational neuroscience and the systems biology research communities. In this review I reconstruct the history of the two disciplines and show that this may explain why they grew up apart. The separation is a pity, as both fields can learn quite a bit from each other. Several examples are given, covering sociological, software technical, and methodological aspects. Systems biology is a better organized community which is very effective at sharing resources, while computational neuroscience has more experience in multiscale modeling and the analysis of information processing by biological systems. Finally, I speculate about how the relationship between the two fields may evolve in the near future

Effect of Product Structure on Manual Assembly Performance

The effect of product structure and availability of assembly instructions were investigated in an experiment. Two products that differed in the order of assembly were used. Both structures had 64 identical parts. One was a vertical assembly built bottom-up, and the other was a hierarchical assembly, which consisted of several subassemblies. Predetermined Motion Time (PMT) analysis showed that the assembly time for both products was identical. Twenty-four test subjects participated in a 2 × 2 factorial between-subject experiment, in which they assembled either of the two products with or without instructions. Because learning and performance are potentially influenced by subject aptitude, cognitive test scores on visual memory, visualization, and spatial orientation were also investigated as influences on manual assembly performance in this task. The hierarchical product took significantly longer time to assemble compared to the vertical. Actual assembly times were also much higher than those predicted using PMT analysis, suggesting that PMT analysis is insufficient to differentiate between designs that differ in complexity. There were no differences between the instructional conditions and individual differences on test scores

RASA2 ablation in T cells boosts antigen sensitivity and long-term function.

The efficacy of adoptive T cell therapies for cancer treatment can be limited by suppressive signals from both extrinsic factors and intrinsic inhibitory checkpoints1,2. Targeted gene editing has the potential to overcome these limitations and enhance T cell therapeutic function3-10. Here we performed multiple genome-wide CRISPR knock-out screens under different immunosuppressive conditions to identify genes that can be targeted to prevent T cell dysfunction. These screens converged on RASA2, a RAS GTPase-activating protein (RasGAP) that we identify as a signalling checkpoint in human T cells, which is downregulated upon acute T cell receptor stimulation and can increase gradually with chronic antigen exposure. RASA2 ablation enhanced MAPK signalling and chimeric antigen receptor (CAR) T cell cytolytic activity in response to target antigen. Repeated tumour antigen stimulations in vitro revealed that RASA2-deficient T cells show increased activation, cytokine production and metabolic activity compared with control cells, and show a marked advantage in persistent cancer cell killing. RASA2-knockout CAR T cells had a competitive fitness advantage over control cells in the bone marrow in a mouse model of leukaemia. Ablation of RASA2 in multiple preclinical models of T cell receptor and CAR T cell therapies prolonged survival in mice xenografted with either liquid or solid tumours. Together, our findings highlight RASA2 as a promising target to enhance both persistence and effector function in T cell therapies for cancer treatment